Patents by Inventor Jacques Lirochon

Jacques Lirochon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody for ADCC And Inducing Cytokine Production
    Publication number: 20100145026
    Abstract: The invention concerns chimeric monoclonal antibodies, humanized or human produced in selected cell lines, said antibodies exhibiting high affinity for the CD16 receptor of effector cells of the immune system and hence capable of inducing high ADCC, but also the property of inducing cytokine and interleukin secretion, in particular IFN?, which can enhance the ADCC activity of effector cells and hence be used for treating cancers and infections by pathogenic agents.
    Type: Application
    Filed: October 8, 2009
    Publication date: June 10, 2010
    Inventors: Christophe de ROMEUF, Arnaud GLACET, Jacques LIROCHON, Dominique BOUREL
  • Antibody for adcc and inducing cytokine production
    Publication number: 20060127392
    Abstract: The invention concerns chimeric monoclonal antibodies, humanized or human produced in selected cell lines, said antibodies exhibiting high affinity for the CD16 receptor of effector cells of the immune system and hence capable of inducing high ADCC, but also the property of inducing cytokine and interleukin secretion, in particular IFN?, which can enhance the ADCC activity of effector cells and hence be used for treating cancers and infections by pathogenic agents.
    Type: Application
    Filed: September 15, 2003
    Publication date: June 15, 2006
    Applicant: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOETCHNOLOGIES
    Inventors: Christophe de Romeuf, Arnaud Glacet, Jacques Lirochon, Dominique Bourel